Matches in Nanopublications for { ?s ?p "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- NP321918.RAf0e1uNbN4WU_f3Uu2h-yrdg3YQ_uQB5kBKnxmT6cIJU130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321918.RAf0e1uNbN4WU_f3Uu2h-yrdg3YQ_uQB5kBKnxmT6cIJU130_provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP698091.RA7IKKL8jf3jqYy8EXPt0469CyE72i4t-YblqaVqX4G2I130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698091.RA7IKKL8jf3jqYy8EXPt0469CyE72i4t-YblqaVqX4G2I130_provenance.
- NP131495.RARtROUNbtbf0wdPJaKEj3jilPf25bD3lrBMDrlgN8HJ8130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131495.RARtROUNbtbf0wdPJaKEj3jilPf25bD3lrBMDrlgN8HJ8130_provenance.
- NP131497.RARmo-f4w2ERsa1zOtgfjzS4cyYYlz7UlYAx3VtqinobI130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131497.RARmo-f4w2ERsa1zOtgfjzS4cyYYlz7UlYAx3VtqinobI130_provenance.
- NP131498.RASClWLzBGlZ66iKAqtJ_49Z0r8CaexLrL6elwu-wTX0E130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131498.RASClWLzBGlZ66iKAqtJ_49Z0r8CaexLrL6elwu-wTX0E130_provenance.
- NP359802.RAOJp3a5fHgWAwyLyHHq1GcgibvuOhBJfLZWQS_geVtrc130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP359802.RAOJp3a5fHgWAwyLyHHq1GcgibvuOhBJfLZWQS_geVtrc130_provenance.
- NP698092.RAd-cSd6eaNMLW9QJMVkNh_0mnYMOUsFr4z30n5eJvyx8130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698092.RAd-cSd6eaNMLW9QJMVkNh_0mnYMOUsFr4z30n5eJvyx8130_provenance.
- NP698093.RAQeXh5tJ_OJXJ4RNMI4ltPfHEMrguR_RD3ECO6M6NYzs130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698093.RAQeXh5tJ_OJXJ4RNMI4ltPfHEMrguR_RD3ECO6M6NYzs130_provenance.
- NP131496.RArX57BgOMXuHAallxP_mb478fC225stc5yugE7E4Hnp4130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP131496.RArX57BgOMXuHAallxP_mb478fC225stc5yugE7E4Hnp4130_provenance.
- NP698089.RAmNf__hhyX4fuD6jGs2LYSSdlY9lcnqkrJgBXTPM9LLc130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698089.RAmNf__hhyX4fuD6jGs2LYSSdlY9lcnqkrJgBXTPM9LLc130_provenance.
- NP359461.RAi4FLIdUNPclq_c5UcSNoBeu9LC11xpjIGmsZMFXeumw130_assertion description "[Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP359461.RAi4FLIdUNPclq_c5UcSNoBeu9LC11xpjIGmsZMFXeumw130_provenance.